Sujal Patel is the co-founder and CEO of Nautilus Biotechnology, a life sciences company pioneering single-molecule proteome analysis to revolutionize how researchers understand proteins.
Before founding Nautilus, Sujal founded and served as CEO of Isilon Systems, which completed one of the most successful IPOs of 2006 before being acquired by EMC in 2010 for $2.6 billion. He served as President of EMC's Isilon Storage Division from 2010 to 2012, where the business generated over $25 billion in lifetime revenue.
At Nautilus, Sujal leads development of the Nautilus Proteome Analysis Platform, which uses single-molecule technology to achieve comprehensive proteome coverage at unprecedented scale. The platform analyzes billions of protein molecules simultaneously, enabling researchers to map proteoform modifications critical to understanding diseases like Alzheimer's and other neurodegenerative disorders.
With nineteen patents in storage and networking plus five patents for Nautilus' proteomics innovations, and having raised approximately $500 million to build the platform, Sujal's journey from tech entrepreneur to biotech CEO demonstrates how interdisciplinary experience can tackle humanity's biggest challenges.
.png)
.png)